Nuclear Medicine Exam 2 UPDATED ACTUAL Questions and CORRECT Answers
Define the term interventional agent and explain how this
Name the two devices necessary to produce the radionu-
clides used in nuclear medicine.
Identify radiopharmaceuticals commonly obtained from a
cyclotron and those commonly obtained from a nuclear
reactor.
Name the radionuclide most commonly utilized in nuclear
medicine and its parent.
Name what the chemical form Tc-99m is in when it is
eluted from the generator.
Identify anatomical sites that pertechnetate will localize.
Give two reasons why gamma-emitting radionuclides are
preferred over other types of radiation emissions for nu-
clear medicine studies.
Differentiate the radiation safety practices used in the
nuclear pharmacy from the nuclear medicine department.
Differentiate a radionuclide from a radiopharmaceutical.
Explain the general purpose of USP 797 guidelines.
Identify the five items of information needed when a
radiopharmaceutical dose is ordered from the nuclear
pharmacy.
, They are energetic enough to pass through patients but
particle accelerator
cause less damage.
(cyclotron)nuclear reactor
Time: work eflciently
Cyclotron: Thalium 201, Iodine 123, Flourine 18
Distance: L-block, etc.
Nuclear reactor: molybdenum 99 (Tc 99 parent)
Shielding: thicker shields (syringe/vials)
-Technetium 99 (Tc99m) radionuclide- no extra directing it to parts of the body it
-molybdenum (99MO) (parent) would not naturally go to
99mTc04- guidelines for preparation of sterile drugs
99m Technetium Pertechnetate aseptic tech/sterility
thyroid (most prominent uptake) patient name
salivary glands procedure
gastric radiopharmaceutical
mucosa dosage amount
choroid time of administration
plexus
1/8
dose differs from a radiopharmaceutical.
Define the term interventional agent and explain how this
Name the two devices necessary to produce the radionu-
clides used in nuclear medicine.
Identify radiopharmaceuticals commonly obtained from a
cyclotron and those commonly obtained from a nuclear
reactor.
Name the radionuclide most commonly utilized in nuclear
medicine and its parent.
Name what the chemical form Tc-99m is in when it is
eluted from the generator.
Identify anatomical sites that pertechnetate will localize.
Give two reasons why gamma-emitting radionuclides are
preferred over other types of radiation emissions for nu-
clear medicine studies.
Differentiate the radiation safety practices used in the
nuclear pharmacy from the nuclear medicine department.
Differentiate a radionuclide from a radiopharmaceutical.
Explain the general purpose of USP 797 guidelines.
Identify the five items of information needed when a
radiopharmaceutical dose is ordered from the nuclear
pharmacy.
, They are energetic enough to pass through patients but
particle accelerator
cause less damage.
(cyclotron)nuclear reactor
Time: work eflciently
Cyclotron: Thalium 201, Iodine 123, Flourine 18
Distance: L-block, etc.
Nuclear reactor: molybdenum 99 (Tc 99 parent)
Shielding: thicker shields (syringe/vials)
-Technetium 99 (Tc99m) radionuclide- no extra directing it to parts of the body it
-molybdenum (99MO) (parent) would not naturally go to
99mTc04- guidelines for preparation of sterile drugs
99m Technetium Pertechnetate aseptic tech/sterility
thyroid (most prominent uptake) patient name
salivary glands procedure
gastric radiopharmaceutical
mucosa dosage amount
choroid time of administration
plexus
1/8
dose differs from a radiopharmaceutical.
